Comparison of Haploidentical and Umbilical Cord Blood Transplantation after Myeloablative Conditioning

By
Justin.choi
-
0
36
Researchers evaluated outcomes in patients with hematological malignancy treated with myeloablative conditioning prior to haplo or umbilical cord blood hematopoietic stem cell transplantation.
[Blood Advances]
6445218 {6445218:KDKENBYQ} 1 apa 50 default 1 166334 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22KDKENBYQ%22%2C%22library%22%3A%7B%22id%22%3A6445218%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Wagner%20et%20al.%22%2C%22parsedDate%22%3A%222021-08-30%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BWagner%2C%20J.%20E.%2C%20Ballen%2C%20K.%20K.%2C%20Zhang%2C%20M.-J.%2C%20Allbee-Johnson%2C%20M.%2C%20Karanes%2C%20C.%2C%20Milano%2C%20F.%2C%20Verneris%2C%20M.%20R.%2C%20Eapen%2C%20M.%2C%20%26amp%3B%20Brunstein%2C%20C.%20G.%20%282021%29.%20Comparison%20of%20haploidentical%20and%20umbilical%20cord%20blood%20transplantation%20after%20myeloablative%20conditioning.%20%26lt%3Bi%26gt%3BBlood%20Advances%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3Bbloodadvances.2021004462%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1182%5C%2Fbloodadvances.2021004462%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1182%5C%2Fbloodadvances.2021004462%26lt%3B%5C%2Fa%26gt%3B%20%26lt%3Ba%20title%3D%26%23039%3BCite%20in%20RIS%20Format%26%23039%3B%20class%3D%26%23039%3Bzp-CiteRIS%26%23039%3B%20data-zp-cite%3D%26%23039%3Bapi_user_id%3D6445218%26amp%3Bitem_key%3DKDKENBYQ%26%23039%3B%20href%3D%26%23039%3Bjavascript%3Avoid%280%29%3B%26%23039%3B%26gt%3BCite%26lt%3B%5C%2Fa%26gt%3B%20%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Comparison%20of%20haploidentical%20and%20umbilical%20cord%20blood%20transplantation%20after%20myeloablative%20conditioning%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20E.%22%2C%22lastName%22%3A%22Wagner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karen%20Kuhn%22%2C%22lastName%22%3A%22Ballen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mei-Jie%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mariam%22%2C%22lastName%22%3A%22Allbee-Johnson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chatchada%22%2C%22lastName%22%3A%22Karanes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Filippo%22%2C%22lastName%22%3A%22Milano%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20R%22%2C%22lastName%22%3A%22Verneris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary%22%2C%22lastName%22%3A%22Eapen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudio%20G%22%2C%22lastName%22%3A%22Brunstein%22%7D%5D%2C%22abstractNote%22%3A%22Haploidentical%20hematopoietic%20stem%20cell%20transplantation%20%28haplo%20HSCT%29%20has%20emerged%20as%20an%20important%20treatment%20modality.%20Most%20reports%20comparing%20haplo%20HSCT%20with%20post-transplant%20cyclophosphamide%20%28PTCy%29%20and%20other%20donor%20sources%20have%20focused%20on%20outcomes%20in%20older%20adults%20treated%20with%20reduced%20intensity%20conditioning.%20%20Therefore%2C%20in%20the%20current%20study%2C%20we%20evaluated%20outcomes%20in%20patients%20with%20hematological%20malignancy%20treated%20with%20myeloablative%20conditioning%20prior%20to%20haplo%20%28n%3D375%29%20or%20umbilical%20cord%20blood%20%28UCB%2C%20n%3D333%29%20HSCT.%20%20All%20haplo%20recipients%20received%20a%204%20of%208%20HLA%20matched%20graft%20while%20recipients%20of%20UCB%20were%20matched%20at%206-8%5C%2F8%20%28n%3D145%29%20or%20%5Cu22645%5C%2F8%20%28n%3D188%29%20HLA%20antigens.%20Recipients%20of%206-8%5C%2F8%20UCB%20transplants%20were%20younger%20%2814%20years%20vs.%2021%20and%2029%20years%29%20and%20more%20likely%20to%20have%20lower%20co-morbidity%20scores%20compared%20to%20recipients%20of%20%5Cu22645%5C%2F8%20UCB%20and%20haplo%20HSCT%20%2881%25%20vs.%2069%25%20and%2063%25%2C%20respectively%29.%20UCB%20recipients%20were%20more%20likely%20to%20have%20acute%20lymphoblastic%20leukemia%20and%20transplanted%20in%20second%20complete%20remission%20%28CR%29%20whereas%20haplo%20HSCT%20recipients%20were%20more%20likely%20to%20have%20acute%20myeloid%20leukemia%20in%20first%20CR.%20Other%20characteristics%2C%20including%20cytogenetic%20risk%20were%20similar.%20Survival%20at%203%20years%20was%20similar%20for%20the%20donor%20sources%20%2866%25%20haplo%20and%2061%25%20after%20%5Cu22645%5C%2F8%20and%2058%25%20after%206-8%5C%2F8%20UCB%29.%20%20Notably%2C%20relapse%20at%203%20years%20was%20lower%20in%20recipients%20of%20%5Cu22645%5C%2F8%20UCB%20%2821%25%2C%20p%3D0.03%29%20compared%20to%20haplo%20%2836%25%29%20and%206-8%5C%2F8%20UCB%20%2830%25%29.%20However%2C%20non-relapse%20mortality%20was%20higher%20in%20%5Cu22645%5C%2F8%20UCB%20%2821%25%29%20compared%20to%20other%20groups%20%28p%26lt%3B0.0001%29.%20These%20data%20suggest%20that%20haplo%20HSCT%20with%20PTCy%20after%20myeloablative%20conditioning%20provides%20an%20overall%20survival%20outcome%20comparable%20to%20that%20after%20UCB%20regardless%20HLA%20match%20group.%22%2C%22date%22%3A%22August%2030%2C%202021%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1182%5C%2Fbloodadvances.2021004462%22%2C%22ISSN%22%3A%222473-9529%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1182%5C%2Fbloodadvances.2021004462%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-08-31T22%3A31%3A39Z%22%7D%7D%5D%7D
Wagner, J. E., Ballen, K. K., Zhang, M.-J., Allbee-Johnson, M., Karanes, C., Milano, F., Verneris, M. R., Eapen, M., & Brunstein, C. G. (2021). Comparison of haploidentical and umbilical cord blood transplantation after myeloablative conditioning. Blood Advances, bloodadvances.2021004462. https://doi.org/10.1182/bloodadvances.2021004462 Cite
Abstract